Neuroinflammatory processes occur in many psychiatric and neurological diseases. Our main goal is to generate new and useful pharmacological strategies in neuropsychiatric pathologies, as well as the search for biomarkers. We also focus on identifying and to developing pharmacological tools in order to improve the quality of treatments for patients suffering these diseases. Our specific […]
